Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Benoit

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Gynecology Obstetrics and Human Reproduction|May 10, 2024
Prognostic value of BRCA1 promoter methylation for patients with epithelial ovarian cancerHenri Azaïs, Simon Garinet, Louise Benoit, et al.
Clinical Breast Cancer|March 21, 2026
SENOPAUSE: Evaluation of an ASCO-Derived Clinical Proxy for Axillary Risk Stratification in a Retrospective CohortMichel Gabriel Cazenave, Katia Mahiou, Leslie Elahi, et al.
Bulletin Du Cancer|March 6, 2025
[Prophylactic hysterectomy (Lynch syndrome, BRCA and others)]Constance Maudot, Meriem Koual, Henri Azaïs, et al.
Gynecologic Oncology|July 4, 2021
What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?Louise Benoit, Jonathan Zerbib, Meriem Koual, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2021
Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancerLouise Benoit, Meriem Koual, Marie-Aude Le Frère-Belda, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 1, 2023
Clinical use of Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer in France in 2021Louise Benoit, Axelle Gillet de Thorey, Manuel Gomes David, et al.
Scientific Reports|November 25, 2025
Transcriptome study exploring the mechanisms linking pollutants and breast cancer aggressivenessLouise Benoit, German Cano-Sancho, Céline Tomkiewicz, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 12, 2025
Improved tumor-type informed compared to tumor-informed mutation tracking for ctDNA detection and microscopic residual disease assessment in epithelial ovarian cancerMehdi Ben Sassi, Henri Azais, Charles Marcaillou, et al.
Journal of Gynecology Obstetrics and Human Reproduction|July 29, 2024
Exploring uterine involvement in hysterectomy samples following conization for adenocarcinoma in situ of the uterine cervix: Insights from a multicenter study by the FRANCOGYN groupMarjolaine Le Gac, Louise Benoit, Meriem Koual, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2023
Patterns of recurrence in surgically treated women for TP53-mutated endometrial carcinomasFlore-Anne Pain, Guillaume Beinse, Henri Azaïs, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Gynecology Obstetrics and Human Reproduction|May 10, 2024
Prognostic value of BRCA1 promoter methylation for patients with epithelial ovarian cancerHenri Azaïs, Simon Garinet, Louise Benoit, et al.
Clinical Breast Cancer|March 21, 2026
SENOPAUSE: Evaluation of an ASCO-Derived Clinical Proxy for Axillary Risk Stratification in a Retrospective CohortMichel Gabriel Cazenave, Katia Mahiou, Leslie Elahi, et al.
Bulletin Du Cancer|March 6, 2025
[Prophylactic hysterectomy (Lynch syndrome, BRCA and others)]Constance Maudot, Meriem Koual, Henri Azaïs, et al.
Gynecologic Oncology|July 4, 2021
What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?Louise Benoit, Jonathan Zerbib, Meriem Koual, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2021
Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancerLouise Benoit, Meriem Koual, Marie-Aude Le Frère-Belda, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 1, 2023
Clinical use of Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer in France in 2021Louise Benoit, Axelle Gillet de Thorey, Manuel Gomes David, et al.
Scientific Reports|November 25, 2025
Transcriptome study exploring the mechanisms linking pollutants and breast cancer aggressivenessLouise Benoit, German Cano-Sancho, Céline Tomkiewicz, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 12, 2025
Improved tumor-type informed compared to tumor-informed mutation tracking for ctDNA detection and microscopic residual disease assessment in epithelial ovarian cancerMehdi Ben Sassi, Henri Azais, Charles Marcaillou, et al.
Journal of Gynecology Obstetrics and Human Reproduction|July 29, 2024
Exploring uterine involvement in hysterectomy samples following conization for adenocarcinoma in situ of the uterine cervix: Insights from a multicenter study by the FRANCOGYN groupMarjolaine Le Gac, Louise Benoit, Meriem Koual, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2023
Patterns of recurrence in surgically treated women for TP53-mutated endometrial carcinomasFlore-Anne Pain, Guillaume Beinse, Henri Azaïs, et al.
Pageof 5